Skip to content
Smart Scholars🛡 Scholar Shield🏛 Research Integrity Desk🧩 Portfolio Console📰 Journals🔧 DOI MembersTools🔎 Journal AuditGI GetIndexedDr DOI Doctor

10.46243/jst.2020.v5.i3.pp19-24 registered

Aptamer: A New Class of Oligonucleotide for Therapeutic and Diagnostic Use - Review

Resolves to https://www.jst.org.in/index.php/pub/article/view/333

Held by Longman Publishers (India) · prefix 10.46243 live · DOI address https://doi.org/10.46243/jst.2020.v5.i3.pp19-24

Registered 29 Sep 2026 via crossref · record version 2 · last change 29 Sep 2026, 11:59 PM · record sha256 0731ce686ad56bda…

Resolve ⬇ Record (JSON) ⬇ Kernel Metadata Declaration (XML) Compare with Crossref Cite (APA · BibTeX · RIS · CSL)

Also as schema.org JSON-LD · Turtle · RDF/XML · DataCite XML (not for this record) · Crossref UNIXREF · Crossref UNIXSD — the formats of the DOI content-negotiation service, from this record (which carries what).

What the DOI identifies

JournalArticle — an article in a journal · Digital · Visual · en

Aptamer: A New Class of Oligonucleotide for Therapeutic and Diagnostic Use - Review (PrincipalTitle · en)

Published 2020-04-29

Part of Journal of Science & Technology · ISSN 2456-5660 · volume 5 · issue 3 · pages 19–24

Agents

  • Longman Publishers (publisher)

Identifiers DOI 10.46243/jst.2020.v5.i3.pp19-24

Abstract · en

Recently, aptamers get the attention of many scientist, because they have all advantages of antibodies which found in human body. They also have unique merits like thermal stability, low cost, and many more. Aptamers are the short sequence nucleic acid with a high affinity and specificity. It is globally adopted as a one of the advance and promising drug delivery technique. These aptamers are produced by in vitro selection method using SELEX technique. This review contains the discussion on the aspect of design, unique properties, applications of aptamers to aid in cancer diagnosis, prevention and treatment under fine condition. Finally, several medical and analytical applications are presented.

Licence https://creativecommons.org/licenses/by/4.0

System metadata — ISO 26324:2025, Annex B · DOI Handbook 10.1

Each element by the standard's name (Annex B: reference elements, then administrative) and the Handbook's (in grey), read off the record above.

ElementValueIn the record
DOI Name
DOI name
10.46243/jst.2020.v5.i3.pp19-24doi
Referent Type
referentType
Creationreferent
Referent Sub-Type
referentSubType
JournalArticle — an article in a journaltype
Referent Name(s)
referentName(s)
Aptamer: A New Class of Oligonucleotide for Therapeutic and Diagnostic Use - Review (PrincipalTitle, en)titles
Basic Metadata
basicMetadata
publisher: Longman Publishers
published: 2020-04-29
part of: Journal of Science & Technology · ISSN 2456-5660 · vol. 5 · no. 3 · pp. 19–24
language: en
form: Digital · Visual · Language
agents, dates, container, language, structural_type, modes, characters
Referent Identifier(s)
alternateIdentifier(s)
none besides the DOIidentifiers, relations (IsSameAs)
Registration Authority
registrationAuthorityCode
Crossref — issued by Crossref (member 25296); held here as a copyrecord.source_agency (our code, ra_doi_name, for names issued here once appointed)
Created Date
issueDate
2020-04-29record.registered (when the DOI name was first registered)
relatedIdentifiersnone needed — the descriptive metadata is in this recordcontainer, relations (only where the descriptive metadata lives at another identifier)

complete Every System Metadata element is here, with the basic metadata a journal article needs.

Recommended for a journal article and not in this record: its author(s), editor(s) or corporate author.

The System Metadata Declaration (JSON) · the Kernel Metadata Declaration (XML) · what each sub-type needs

Cited by — in this registry

No record held in this registry cites this DOI.

Counts only records held in this registry; a citation from a work held elsewhere is not seen here. The list as JSON

References with DOIs

The record lists 23 references; 23 carry a DOI.

#ReferenceDOIHeld here
1ref1 Zhang,Y.,et.al. Tumor-Targeted Drug Delivery with Aptamers. Curr. Med. Chem.2011. 18(27): 4185-9410.2174/092986711797189547not held here
2ref2 Sun,H.et al. Oligonucleotide Aptamers: New Tools for Targeted Cancer Therapy. Molecular Therapy Nucleic Acids. 2014.3, e182. Doi: 10.1038/mtna.2014.3210.1038/mtna.2014.32not held here
3ref3 Jayasena, S.D. Apatmers: An emerging class of molecules that rival antibodies in diagnostics. Clinical Chemistry.1999.45(9): 1628-5010.1093/clinchem/45.9.1628not held here
4ref4 Vinkenborg, J.L.,et al. Aptamers for allosteric regulations. Nature Chemical Biology. August 2011.7;519-2710.1038/nchembio.609not held here
5ref5 Xu, Li, et al. Cellular Internalization and Cytotoxicity of Aptamers Selected from Lung Cancer cell. American Journal of Biomedical Sciences. 24 December 201210.5099/aj130100047not held here
6ref6 Kabori, S.et al. Kinetic analysis of aptazyme-regulated gene expression in a cell- free translation system: Modeling of liganddependant and-independent expression. RNA.2012.18(8):…10.1261/rna.032748.112not held here
7ref7 A.V. Lakhin, V.Z. Taranful, Aptamers: Problems, Solution and Prospects, Acta Naturae. 2013 Oct-Dec; 5(4): 34–4310.32607/20758251-2013-5-4-34-43not held here
8ref8 Colas P, Cohen B, “Genetic selection of peptide aptamers that recognize and inhibit cyclin-dependant kinase 2” Nature 380(6574):548-5010.1038/380548a0not held here
9ref9 Mohamad H. Ali, Marwa E. Elsherbiny, Review update on aptamer research. Int. J. Mol. Sci. 2019, 20,251110.3390/ijms20102511not held here
10ref10 Yang Zhang,BoShiun Lai, Review on Recent Advances in Aptamer Discovery and Application, Molecules 2019,2410.3390/molecules24050941not held here
11ref11 ZhenjjanZhuo, Yuanyanyu, Recent Advances in SELEX Technology and Aptamer Application in Biomedicine, Int. J. Mol.Sci, 2017, 18 (10):214210.3390/ijms18102142not held here
12ref12 Tatjana Schutze, Barbara Wilhelm, Probing the SELEX Process with Next–Generation Sequencing,Journal pone,201110.1371/journal.pone.0029604not held here
13ref13 Baby Santosh, Promad, K, Yadava, Review article on Nucleic Acid Aptamers: Research Tool in Disease Diagnostic and Therapeutics, BioMed Research International Volume 201410.1155/2014/540451not held here
14ref14 D. J. Stickle,J.B. King, Blockage of uretheral catheters by bacterial biofilms, Journal of Infection,1993, Vol.27,no.2, P.NO. 133-10.1016/0163-4453(93)94620-qnot held here
15ref15 W. C. Winkler, R. R. Breaker, “ Regulation of bacterial gene expression by riboswitches, Annual Review of Microbiology, 2005, vol.29, P.No- 487-51710.1146/annurev.micro.59.030804.121336not held here
16ref16 Kyung Mi-Song,Seonghwan Lee, “Aptamer and Their Biological Application,’’ Sensors 2012, 12, 612-63110.3390/s120100612not held here
17ref17 B. J. Tucker and R.R. Breaker, Riboswitches as versatile gene control element, Current Opinion in Structural Biology,2005, vol. 15, no.3, P.No. 342-348.expected places, Wiley Inter10.1016/j.sbi.2005.05.003not held here
18ref18 K. Matyalla-Kulinska, J.L. Boots, Finding aptamers and small ribozymes in unexpected place, Wiley Interdisciplinary Review : RNA, 2012, vol.3, no.1, P.No.73-9110.1002/wrna.105not held here
19ref19 Y.Wan, Y.Kim, N.et al., “Surface-immobilized aptamers for cancer cell isolation and microscopic cytology’’ Cancer Research, 2010,vol.70,no.22, P.No-9371-938010.1158/0008-5472.can-10-0568not held here
20ref20 P.Zhang, N. Zhao, “ Using an RNA Aptamer probe for flow cytometry detection of CD30 expressing lymphoma cells’’ Laboratory Investigation,2009,vol.89,no.12, P.No-1423-143210.1038/labinvest.2009.113not held here
21ref21 D.H.J. Bunka, P.G. Stockley, “Aptamers come of age-at last’’ Nature Reviews Microbiology, 2006,vol.4, no.8, P.No-588-59610.1038/nrmicro1458not held here
22ref22 T.G. McCauley, N. Hamaguchi, “Aptamer based biosensor arrays for detection and quantification of biological macromolecules’’, Analytical Biochemistry, 2003,vol.319, no.2,P.No- 244…10.1016/s0003-2697(03)00297-5not held here
23ref23 S. Sivanesan, M.D. Howell,” Antisense oligonucleotide mediate therapy of spinal muscular atropy,’’ Translational Neuroscience,2013,vol.4, no.1, P.No-1-710.2478/s13380-013-0109-2not held here

The references as JSON

Relations

The record states no relation, and no record held here states one with this DOI.

The relations as JSON

Funding

The record names no funder.

Each funder's page lists every work held here that names it. ROR IDs open at ror.org; Funder Registry IDs resolve at doi.org.

History — the ledger

Every change to this DOI, in order, as it was recorded. Entries are only ever added, never changed or removed.

#WhenWhatByChanges
129 Sep 2026, 10:00 PMregister
registered at Crossref; record read from api.crossref.org
Administrator (admin) 117 fields set · sha256 32a681c3bc8e…
229 Sep 2026, 11:59 PMupdate
record re-read from api.crossref.org
Administrator (admin)
container.titles.0.value: Journal of Science & Technology → Journal of Science & Technology
titles.0.value: Aptamer: A New Class of Oligonucleotide for Therapeutic and Diagnostic Use - Review → Aptamer: A New Class of Oligonucleotide for Therapeutic and Diagnostic Use - Review

Machine-readable: the history as JSON, with the full record after each change.

Share this page

Share this page

Ask AI about this page

Everything Smart Scholars runs

Nine sites, one account. A journal starts at the audit; an author starts at Scholar Shield.

What we do: DOIs registered from what a journal already has · Crossref records completed — references, abstracts, licences, ORCID iDs, affiliations and ROR IDs, funding · DOIs that resolve · articles preserved · journals rated on the public record · see everything we do →

Book a free call

For journals & publishers

Start with the audit — ₹4,999 per journal, and the gate to everything else.

DOI care

Every service on one journal profile — each previews first and acts only on your approval.

  • DOI Doctor — check & repairevery DOI tested at doi.org and Crossref; dead links, abstracts, licences, ORCIDs
  • Smart Deposita new DOI from your PDF, Word file, article page, JATS XML or spreadsheet — every value shown with its source, deposited once you confirm it
  • DOI census (Excel)site against Crossref, both directions, with a copy-paste fix per article
  • Backfile DOIsDOIs for older articles that never had one — no per-DOI fee of ours
  • DOIs for conference proceedingsthe conference, the volume and every paper — registered in the organiser's own name
  • Scopus indexing guidethe minimum criteria, the 14 CSAB criteria and how a title is suggested — from Elsevier's own page
  • Embase indexing guidewhat Embase asks of a biomedical journal and how to suggest it
  • Write DOIs into OJSthe verified DOIs pushed onto your article pages through your own API
  • Silent-failure monitorweekly checks of site, OAI-PMH, Scholar tags, ISSN, preservation, hijack lists
  • Journal Radarevery journal, every day: SSL, DNS, redirects, robots.txt, OJS, DOIs, Crossref metadata, broken links — what broke since yesterday first
  • Verified metrics & badgesa public, dated, source-linked metrics page and a "cited by" badge
  • Quality dossier (PDF)one PDF for universities, authors and reviewers
  • Author citation enginethe citation steps emailed to each author from the journal's own mailbox
  • JATS XMLmachine-readable JATS per article
  • Duplicate articlesthe same paper published twice — you choose which copy stays

For authors & researchers

Free to use. Nothing you check is shared with the journal.

For institutions, sponsors & DOI operators

Smart Scholars

Mon–Sat, 10:00–19:00 IST. The Ask AI button on every page answers about our services at any hour.

News

Policies

What we can register a DOI for

20 kinds of record, one account, one place. Every one gets a DOI that resolves, metadata that indexes read, and a record that stays correct afterwards.

Journals

  • Journal articles
  • Journal titles
  • Pending publications
  • Peer reviews
  • Preprints & posted content

Books & conferences

  • Books
  • Book chapters
  • Book series
  • Book sets
  • Conference proceedings
  • Proceedings series
  • Conference papers

Other research output

  • Theses & dissertations
  • Reports & working papers
  • Report series
  • Standards
  • Databases
  • Datasets
  • Figures, tables & supplements

Funding

  • Grants & funding awards

Elsewhere

The same company, in the places our publishers already read.
Add Smart Scholars as a preferred source on GoogleSee more of our newsroom in Google’s Top Stories.
Smart Scholars · Every service on one pageNewsroom posts CC BY 4.0 · DOI metadata CC0 · everything else ©Data from OpenAlex (openalex.org), CC0 · Crossref · ISSN Portal · DOAJContact
WhatsApp